主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Ma Yan Yin Jun Maerkeya Kamalibaike Guo Runmei Li Li
英文单位:Department of Gynecology Affiliated Tumor Hospital of Xinjiang Medical University Urumqi 830011 China
关键词:宫颈癌;内质网膜蛋白复合物亚单位6;Hela细胞;细胞自噬;放射线敏感性
英文关键词:Cervicalcancer;Endoplasmicreticulummembraneproteincomplexsubunit6;Helacells; Autophagy;Radiosensitivity
目的 探讨内质网膜蛋白复合物亚单位6(EMC6)调控细胞增殖和凋亡对宫颈癌Hela细胞放射线敏感性的影响。方法 将宫颈癌Hela细胞分为CON组(正常宫颈癌Hela细胞)、shCtrl组(EMC6基因空白质粒转染宫颈癌Hela细胞)和shEMC6组(EMC6基因短发夹RNA干扰表达质粒转染宫颈癌Hela细胞),给予2、4、6、8 Gy X线外照射处理,照射处理后采用定量聚合酶链反应法检测EMC6 mRNA表达水平,蛋白质印迹法检测EMC6蛋白表达水平,克隆形成实验检测细胞增殖水平,流式细胞术检测细胞凋亡水平和细胞周期。结果 shEMC6组EMC6 mRNA表达水平低于shCtrl组[(0.530±0.017)比(1.004±0.108)](P=0.002),EMC6的敲减率为47.24%。shEMC6组EMC6蛋白表达水平低于shCtrl组[(0.506±0.012)比(0.528±0.005)](P=0.023)。2、4 Gy X线照射处理后,shEMC6组细胞增殖水平均低于shCtrl组和CON组(均P<0.05)。2 Gy X线照射后4、8、12 h,shEMC6组细胞凋亡率均高于shCtrl组[(45.71±0.66)%比(34.86±1.16)%、(13.85±0.24)%比(12.85±0.19)%、(22.74±0.14)%比(17.77±0.40)%],差异均有统计学意义(均P<0.05)。2 Gy X线照射前0 h,shEMC6组S期细胞比例低于shCtrl组,G2期细胞比例高于shCtrl组(均P<0.05);照射后4 h,shEMC6组S期细胞比例低于shCtrl组(P<0.05),G2期细胞比例与shCtrl组比较差异无统计学意义(P>0.05);照射后8 h,shEMC6组S期细胞比例高于shCtrl组,G2期细胞比例低于shCtrl组(均P<0.05);照射后12 h,shEMC6组S期细胞比例与shCtrl组比较差异无统计学意义(P>0.05),G2期细胞比例低于shCtrl组(P<0.05)。结论 宫颈癌Hela细胞沉默EMC6后,细胞增殖减少,同时细胞凋亡和G2期细胞数量显著增加,对放射线的敏感性显著提高。
Objective To investigate the effect of endoplasmic reticulum membrane protein complex subunit 6 (EMC6) regulating cell proliferation and apoptosis on radiosensitivity of cervical cancer Hela cells. Methods Cervical cancer Hela cells were divided into CON group (normal cervical cancer Hela cells), shCtrl group (EMC6 gene blank plasmid was transfected into cervical cancer Hela cells) and shEMC6 group (EMC6 gene short hairpin RNA interference expression plasmid was transfected into cervical cancer Hela cells). They were treated with 2, 4, 6 and 8 Gy X-ray external irradiation. After irradiation, the expression level of EMC6 mRNA was detected by quantitative polymerase chain reaction and the expression level of EMC6 protein was detected by western blotting. The level of cell proliferation was detected by clone formation assay, and the level of apoptosis and cell cycle were detected by flow cytometry. Results The expression level of EMC6 mRNA in shEMC6 group was lower than that in shCtrl group[(0.530±0.017) vs (1.004±0.108)](P=0.002), and the knockdown rate of EMC6 was 47.24%. The expression level of EMC6 protein in shEMC6 group was lower than that in shCtrl group [(0.506±0.012) vs (0.528±0.005)](P=0.023). After 2, 4 Gy X-ray irradiation, the level of cell proliferation in shEMC6 group was lower than that in shCtrl group and CON group (both P<0.05). At 4, 8 and 12 h after 2 Gy X-ray irradiation, the apoptosis rates of shEMC6 group were higher than those of shCtrl group [(45.71±0.66)% vs (34.86±1.16)%, (13.85±0.24)% vs (12.85±0.19)%, (22.74±0.14)% vs (17.77±0.40)%] (all P<0.05). At 0 h before 2 Gy X-ray irradiation, the proportion of S-phase cells in shEMC6 group was lower than that in shCtrl group, and the proportion of G2-phase cells was higher than that in shCtrl group (both P<0.05); 4 h after irradiation, the proportion of S-phase cells in shEMC6 group was lower than that in shCtrl group (P<0.05), and there was no significant difference in the proportion of G2-phase cells between shEMC6 group and shCtrl group (P>0.05); 8 h after irradiation, the proportion of S-phase cells in shEMC6 group was higher than that in shCtrl group, and the proportion of G2-phase cells was less than that in shCtrl group (all P<0.05); 12 h after irradiation, the proportion of S-phase cells in shEMC6 group was not significantly different from that in shCtrl group (P>0.05), and the proportion of G2-phase cells was lower than that in shCtrl group (P<0.05). Conclusion The silencing of EMC6 in Hela cells resulted in a decrease in cell proliferation, together with a significant increase in apoptosis and the number of G2-phase cells, and a significant increase in sensitivity to radiation.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。